Literature DB >> 10503680

Prognostic characteristics of asthma diagnosis in early childhood in clinical practice.

J Wever-Hess1, J M Kouwenberg, E J Duiverman, J Hermans, A M Wever.   

Abstract

A registration study from clinical practice was set up to assess the prognostic value of symptoms and laboratory data at first visit for doctor-diagnosed 'asthma' in early childhood. A total of 419 children aged 0-4 y, who were newly referred to the outpatient department of the Juliana Children's Hospital with possible asthma were enrolled over a 2-y period. Data from history taking, physical examination, laboratory tests for atopic status at first visit and data from follow-up visits were recorded. Two years after the first visit all medical records were reviewed for diagnostic label. The age groups 0-1 y and 2-4 y were analysed separately, because respiratory symptoms are often transient and sensitization to inhalant allergens is uncommon before the age of 2 y. The clinical diagnosis 'asthma' was made in 113 of 231 (49%) children aged 0-1 y and in 144 of 188 (77%) children aged 24 y. Characteristics from history taking indicated shortness of breath was the most prognostic symptom in both age groups. Eczema, wheeze and non-allergic provoking factors (weather conditions) were further predisposing factors in the 0-1 y group, as were allergic provoking factors (inhalant allergens) and absence of ear-nose-throat-history in the 2-4 y group. Adding laboratory data to history total serum IgE had prognostic value, but specific serum IgE against inhalant allergens (Phadiatop) was a strong predisposing factor, especially in the 2-4 y group. These prognostic characteristics may enhance early recognition of asthma in infants and improve asthma care in clinical practice.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10503680     DOI: 10.1080/08035259950168739

Source DB:  PubMed          Journal:  Acta Paediatr        ISSN: 0803-5253            Impact factor:   2.299


  7 in total

1.  Accuracy of specific IgE in the prediction of asthma: development of a scoring formula for general practice.

Authors:  Petra E D Eysink; Gerben ter Riet; Rob C Aalberse; Wim M C van Aalderen; Carel M Roos; Jaring S van der Zee; Patrick J E Bindels
Journal:  Br J Gen Pract       Date:  2005-02       Impact factor: 5.386

Review 2.  Improving the management of atopic disease.

Authors:  S T Holgate; G Lack
Journal:  Arch Dis Child       Date:  2005-08       Impact factor: 3.791

3.  Risk of asthma in children diagnosed with bronchiolitis during infancy: protocol of a longitudinal cohort study linking emergency department-based clinical data to provincial health administrative databases.

Authors:  Kawsari Abdullah; Deshayne B Fell; Dhenuka Radhakrishnan; Steven Hawken; David W Johnson; Piush Mandhane; Teresa To; Gary Joubert; Amy C Plint
Journal:  BMJ Open       Date:  2021-05-03       Impact factor: 2.692

4.  Predicting asthma in preschool children with asthma symptoms: study rationale and design.

Authors:  Esther Hafkamp-de Groen; Hester F Lingsma; Daan Caudri; Alet Wijga; Vincent Wv Jaddoe; Ewout W Steyerberg; Johan C de Jongste; Hein Raat
Journal:  BMC Pulm Med       Date:  2012-10-16       Impact factor: 3.317

5.  Sensitization profile in differential diagnosis: allergic asthma vs. chronic (nonspecific) cough syndrome.

Authors:  Vlado Drkulec; Boro Nogalo; Marija Perica; Davor Plavec; Marija Pezer; Mirjana Turkalj
Journal:  Med Sci Monit       Date:  2013-05-29

Review 6.  A systematic review of predictive models for asthma development in children.

Authors:  Gang Luo; Flory L Nkoy; Bryan L Stone; Darell Schmick; Michael D Johnson
Journal:  BMC Med Inform Decis Mak       Date:  2015-11-28       Impact factor: 2.796

7.  Hospitalization rate and 30-day mortality among patients with status asthmaticus in Denmark: a 16-year nationwide population-based cohort study.

Authors:  Jennie Maria Christin Strid; Henrik Gammelager; Martin Berg Johansen; Else Tønnesen; Christian Fynbo Christiansen
Journal:  Clin Epidemiol       Date:  2013-09-05       Impact factor: 4.790

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.